Short-term androgen deprivation therapy does not improve survival in patients receiving postoperative radiotherapy for prostate cancer
Physician's Weekly,
1. There was no significant difference in metastasis-free survival between the ADT and non-ADT groups over 10 years. 2. Adverse…